The initiative aims to enhance production efficiency and reduce the risk of human error-induced inconsistencies.

SAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the ...

An alliance with a German-based global operator promises further international expansion in the cell and gene therapies ...

Cellular Origins and Fresenius Kabi have partnered to integrate Fresenius Kabi's cell therapy processing tech with Cellular ...

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius ...

Cellular Origins and Fresenius Kabi, an operating company ... treatment while reducing development and manufacturing costs. The U.S. Food and Drug Administration (FDA) has approved flurpiridaz ...

Only children and other patients with specific medical needs should start home peritoneal dialysis for the time being, the ...

Two major hurricanes have had medtech companies, including Baxter, B. Braun and Fresenius, scrambling to prevent a U.S. IV ...

B. Braun and Fresenius Medical Care said they will make more crucial products as the U.S. faces shortages following Hurricane Helene’s damage to a Baxter manufacturing facility.

Employees at Ploeger UK in Fakenham are facing redundancies as a downturn in the agricultural machinery market impacts demand.